S. 891 119th Congress
Bipartisan Health Care Act
Latest action, Mar 6, 2025: Read twice and referred to the Committee on Finance.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
1 cosponsor
Sponsored by Ron Wyden (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
0 D · 0 R · 1 I
- Democrat
- Republican
- Independent
Referred to: Senate: Finance Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE)
SIMS STRATEGIES, LLC
7 reports
AMERICAN ACADEMY OF DERMATOLOGY
CAPITOL COUNSEL LLC
7 reports
AMERICAN ACADEMY OF OPHTHALMOLOGY
CAPITOL COUNSEL LLC
7 reports
AMERICAN COLLEGE OF EMERGENCY PHYSICIANS
CAPITOL COUNSEL LLC
7 reports
7 reports
EISAI, INC.
CROSSROADS STRATEGIES, LLC
7 reports
7 reports
INDEPENDENT PHARMACY COOPERATIVE
FORBES-TATE
7 reports
MERCK & CO., INC.
CROSSROADS STRATEGIES, LLC
7 reports
NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS
MASON CONSULTING, LLC
7 reports
NATIONAL LEAGUE FOR NURSING
MASON CONSULTING, LLC
7 reports
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
CROSSROADS STRATEGIES, LLC
7 reports
All 25 of 85 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE) | SIMS STRATEGIES, LLC | 7 | $50K | Q1 2025 | Q3 2026 | yes |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 7 | $28.6M | Q1 2025 | Q3 2026 | yes | |
| AMERICAN ACADEMY OF DERMATOLOGY | CAPITOL COUNSEL LLC | 7 | $280K | Q1 2025 | Q3 2026 | yes |
| AMERICAN ACADEMY OF FAMILY PHYSICIANS | 7 | $6.0M | Q1 2025 | Q3 2026 | yes | |
| AMERICAN ACADEMY OF OPHTHALMOLOGY | CAPITOL COUNSEL LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| AMERICAN COLLEGE OF EMERGENCY PHYSICIANS | CAPITOL COUNSEL LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| CAMBIA HEALTH SOLUTIONS | 7 | $4.6M | Q1 2025 | Q3 2026 | yes | |
| EISAI, INC. | CROSSROADS STRATEGIES, LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| EMD SERONO INC | 7 | $5.4M | Q1 2025 | Q3 2026 | yes | |
| INDEPENDENT PHARMACY COOPERATIVE | FORBES-TATE | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| MERCK & CO., INC. | CROSSROADS STRATEGIES, LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS | MASON CONSULTING, LLC | 7 | $168K | Q1 2025 | Q3 2026 | yes |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 7 | $2.2M | Q1 2025 | Q3 2026 | yes | |
| NATIONAL LEAGUE FOR NURSING | MASON CONSULTING, LLC | 7 | $201K | Q1 2025 | Q3 2026 | yes |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | CROSSROADS STRATEGIES, LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| SANOFI US SERVICES INC. | CROSSROADS STRATEGIES, LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| TAKEDA PHARMACEUTICALS AMERICA, INC. | CROSSROADS STRATEGIES, LLC | 7 | $0 | Q1 2025 | Q3 2026 | yes |
| US PHYSICIAN PARTNERS (INFORMAL COALITION) | SIMS STRATEGIES, LLC | 7 | $610K | Q1 2025 | Q3 2026 | yes |
| VIATRIS INC | 7 | $3.6M | Q1 2025 | Q3 2026 | yes | |
| AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION | FORBES-TATE | 6 | $0 | Q1 2025 | Q3 2026 | yes |
| AMERICAN MEDICAL ASSOCIATION | 6 | $32.8M | Q1 2025 | Q3 2026 | yes | |
| GSK (FKA GLAXOSMITHKLINE INC.) | 6 | $7.3M | Q1 2025 | Q2 2026 | yes | |
| SOUTHEAST GEORGIA HOSPITAL SYSTEM | CAROL G HOLLADAY & ASSOCIATES | 6 | $120K | Q1 2025 | Q2 2026 | yes |
| 340B HEALTH | 5 | $1.7M | Q1 2025 | Q1 2026 | yes | |
| ALLIANCE FOR REGENERATIVE MEDICINE | 5 | $790K | Q1 2025 | Q1 2026 | yes |